Zuranolone is a medicine used to treat depression that starts during pregnancy or after having a baby. It's taken as a capsule once a day in the evening for 14 days. It works by boosting the effect of GABA, a calming brain chemical.
Every report comes from a Lived member, sent anonymously.
Have you tried Zurzuvae (Zuranolone) for Postpartum Depression?
Zuranolone, sold as Zurzuvae, is a prescription medicine for postpartum depression in adults. Postpartum depression is a major depressive episode that begins late in pregnancy or in the weeks after giving birth, bringing persistent low mood, loss of interest or pleasure, guilt, exhaustion beyond ordinary new-parent tiredness and, for some people, thoughts of self-harm. Approved by the US Food and Drug Administration (FDA) in 2023, it was the first medicine for postpartum depression that can be taken by mouth at home. Unlike most antidepressants, which are taken for months, it is given as a single two-week course. It can be used on its own or added to an antidepressant someone is already taking. It is not approved for other forms of depression.
Zuranolone belongs to a group called neuroactive steroids. It strengthens the effect of GABA (gamma-aminobutyric acid), the brain's main calming chemical messenger, by making the receptors GABA acts on respond more strongly. Pregnancy and birth bring large, rapid shifts in hormones, including natural steroids that also act on these GABA receptors. Researchers think zuranolone may help by steadying brain signaling that these shifts disrupt, though exactly how it relieves postpartum depression is not fully understood. Because it does not work through serotonin the way common antidepressants such as SSRIs (selective serotonin reuptake inhibitors) do, its effects can appear within days rather than weeks. Its calming action on the brain is also the source of its main side effect, sleepiness.
Zurzuvae comes as capsules taken once a day in the evening for 14 days. Each dose should be taken with food that contains some fat, such as an ordinary dinner, because the body absorbs considerably more of the medicine with a meal than on an empty stomach. The usual dose is 50 mg. A prescriber may lower it to 40 mg if sleepiness, dizziness or confusion is a problem, and starts lower for people with severe liver disease, moderate or severe kidney disease, or who take certain medicines that raise zuranolone levels. If an evening dose is missed, skip it and take the next one at the usual time the following evening; do not take extra capsules to catch up. The course still ends after the 14th day, and longer use has not been studied.
Sleepiness is the most common side effect. In the main trial, about a third of people on the full dose felt notably drowsy, compared with about one in seventeen on placebo, and around one in six needed a lower dose. Dizziness, diarrhea, tiredness, cold-like symptoms and urinary tract infections were also more common than with placebo. Because it can make people unsteady, falls are a risk, which matters when carrying a baby or using stairs at night. Confusion is less common but has been severe in a few cases. Marked confusion, or sleepiness that makes it hard to function, should be reported to the prescriber, who may lower the dose or stop the medicine. Depression that gets worse, or new thoughts of suicide or self-harm, need prompt contact with the care team, since a different treatment plan may be needed.
Zurzuvae carries an FDA boxed warning, the agency's strongest, about driving. It slows reaction and impairs driving, and people often cannot tell how impaired they are. Do not drive or do other hazardous tasks, such as operating machinery, until at least 12 hours after each dose, for the whole 14-day course, even if you feel alert. It helps to arrange for someone else to drive during these two weeks. Alcohol and other medicines that cause drowsiness, including benzodiazepines (anti-anxiety medicines such as alprazolam), opioid pain medicines and older tricyclic antidepressants, add to the sedation and can slow breathing. Some other medicines change how quickly the liver clears zuranolone: certain ones raise its levels and call for a lower dose, while others lower its levels enough that the combination should be avoided. A pharmacist can check a full medicine and supplement list. Animal studies suggest zuranolone may harm a developing baby, so effective birth control is advised during treatment and for one week after the last dose. Small amounts pass into breast milk; effects on a breastfed infant are unknown, and the decision is one to weigh with the prescriber. Zuranolone is a Schedule IV controlled substance because it can be misused, so a history of substance use is worth mentioning.
In clinical trials, people taking zuranolone improved more than those on placebo within about three days, and the difference was still there a month after the two-week course ended. Placebo groups also improved substantially, so the added benefit was meaningful but not dramatic, and not everyone responds. The two weeks themselves involve planning: evening doses with a meal, someone else driving, help with night-time baby care if drowsiness is significant, and no alcohol. After the course, follow-up matters. Postpartum depression can persist or return, and ongoing care may include therapy, a standard antidepressant or both.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Zurzuvae (Zuranolone), what you've noticed, or ask the community a question.